华润双鹤：公司全资子公司上海长富腹膜透析液（乳酸盐）系列药品获得药品补充申请批准通知书

Core Viewpoint - China Resources Double Crane (华润双鹤) announced that its wholly-owned subsidiary, Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd. (上海长征富民金山制药有限公司), has received the approval notice from the National Medical Products Administration for the supplementary application of peritoneal dialysis solution (Lactate-G1.5%) and peritoneal dialysis solution (Lactate-G2.5%) [1] Company Summary - The approval pertains to two specific products related to peritoneal dialysis, indicating a potential expansion in the company's product offerings in the medical field [1] - This development may enhance the company's market position in the healthcare sector, particularly in renal care solutions [1]